Bristol-Myers Squibb and Pfizer decided to close out a late-stage clinical trial of their heart drug apixaban--a potential megablockbuster --a couple of months ahead of schedule after concluding they had achieved the kind of results they had hoped for ...

A wide variety of clinical evidence on novel cancer treatments, as well as potential additional uses for existing drugs, were presented at this year’s annual meeting of the American Society of Clinical Oncology, one of the most prestigious events for the sector, taking place over the weekend and through tomorrow in Chicago.